CID 10113978

Pazopanib

Structural Information

Molecular Formula
C21H23N7O2S
SMILES
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
InChI
InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
InChIKey
CUIHSIWYWATEQL-UHFFFAOYSA-N
Compound name
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

1535
References

54683
Patents

437.1634 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 438.17068 201.9
[M+Na]+ 460.15262 215.6
[M+NH4]+ 455.19722 207.1
[M+K]+ 476.12656 209.9
[M-H]- 436.15612 207.3
[M+Na-2H]- 458.13807 210.5
[M]+ 437.16285 205.8
[M]- 437.16395 205.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe